We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMBI icon
2851
Richmond Mutual Bancorp
RMBI
$254M
$827K ﹤0.01%
60,516
+11,315
+23% +$139K
FBIO icon
2852
Fortress Biotech
FBIO
$88.7M
$821K ﹤0.01%
17,270
-3,791
-18% -$164K
STSA
2853
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$818K ﹤0.01%
35,045
-20,774
-37% -$89.5K
CCCC icon
2854
C4 Therapeutics
CCCC
$412M
$816K ﹤0.01%
+24,624
New +$714K
VTOL icon
2855
Bristow Group
VTOL
$1.36B
$816K ﹤0.01%
31,006
-18,065
-37% -$441K
RGCO icon
2856
RGC Resources
RGCO
$228M
$813K ﹤0.01%
34,188
+3,522
+11% +$85.2K
ODC icon
2857
Oil-Dri
ODC
$1.34B
$812K ﹤0.01%
47,690
-216
-0.5% -$3.83K
NBSE
2858
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$805K ﹤0.01%
5,755
-1,686
-23% -$273K
CWCO icon
2859
Consolidated Water Co
CWCO
$488M
$797K ﹤0.01%
66,131
+5,623
+9% +$62.6K
ACNB icon
2860
ACNB Corp
ACNB
$655M
$795K ﹤0.01%
31,809
+6,008
+23% +$144K
SHBI icon
2861
Shore Bancshares
SHBI
$796M
$795K ﹤0.01%
54,471
+11,309
+26% +$145K
RES icon
2862
RPC Inc
RES
$1.3B
$794K ﹤0.01%
252,117
-1,348
-0.5% -$4.05K
MSON
2863
DELISTED
Misonix Inc
MSON
$794K ﹤0.01%
63,543
+867
+1% +$10.9K
PZN
2864
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$791K ﹤0.01%
108,436
-40,788
-27% -$258K
FENC icon
2865
Fennec Pharmaceuticals
FENC
$402M
$790K ﹤0.01%
106,049
+2,439
+2% +$18.6K
GNK icon
2866
Genco Shipping & Trading
GNK
$1.1B
$785K ﹤0.01%
106,623
+531
+0.5% +$3.86K
HBIO icon
2867
Harvard Bioscience
HBIO
$29.2M
$785K ﹤0.01%
18,298
+179
+1% +$6.68K
RYAAY icon
2868
Ryanair
RYAAY
$31.3B
$781K ﹤0.01%
+17,748
New +$697K
SRGA
2869
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$781K ﹤0.01%
11,888
+941
+9% +$61.4K
LCUT icon
2870
Lifetime Brands
LCUT
$211M
$780K ﹤0.01%
51,325
+11,923
+30% +$150K
FSTR icon
2871
Foster
FSTR
$432M
$778K ﹤0.01%
51,685
-8,722
-14% -$128K
HURC icon
2872
Hurco Companies Inc
HURC
$143M
$776K ﹤0.01%
25,844
+1,421
+6% +$43.2K
TBNK
2873
DELISTED
Territorial Bancorp Inc.
TBNK
$776K ﹤0.01%
32,285
+3,341
+12% +$75.1K
GGAL icon
2874
Galicia Financial Group
GGAL
$7.42B
$773K ﹤0.01%
88,467
-18,100
-17% -$143K
KVHI icon
2875
KVH Industries
KVHI
$157M
$773K ﹤0.01%
68,144
+1,102
+2% +$10.9K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.